Article
Combination of late gadolinium enhancement and genotype improves prediction of prognosis in non-ischaemic dilated cardiomyopathy.
European journal of heart failure - 1 Jul 2022
Mirelis Jesús G, Escobar-Lopez Luis, Ochoa Juan Pablo, Espinosa María Ángeles, Villacorta Eduardo, Navarro Marina, Casas Guillem, Mora-Ayestarán Nerea, Barriales-Villa Roberto, Mogollón-Jiménez María Victoria, García-Pinilla José M, García-Granja Pablo E, Climent Vicente, Palomino-Doza Julian, García-Álvarez Ana, Álvarez-Barredo María, Cabrera-Borrego Eva, Ripoll-Vera Tomás, Peña-Peña María Luisa, Rodríguez-González Elena, Gallego-Delgado María, Gonzalez-Carrillo Josefa, Fernández-Ávila Ana, Rodríguez-Palomares José F, Brugada Ramón, Bayes-Genis Antoni, Dominguez Fernando, García-Pavía Pablo
Abstract excerpt
AIMS: Genotype and left ventricular scar on cardiac magnetic resonance (CMR) are increasingly recognized as risk markers for adverse outcomes in non-ischaemic dilated cardiomyopathy (DCM). We investigated the combined influence of genotype and late gadolinium enhancement (LGE) in assessing prognosis in a large cohort of patients with DCM. METHODS AND RESULTS: Outcomes of 600 patients with DCM (53.3 ± 14.1 years,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
